SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis who wrote (247)6/30/1998 12:38:00 AM
From: Jeffrey L. Henken  Read Replies (2) of 410
 
TA Update: Market Edge Second Opinion Upgrades AVEI to a neutral rating:

STOCK SHOWS STRONGLY IMPROVING CONDITIONS SCORE = 3 IF YOU ARE SHORT THIS STOCK CONSIDER COVERING OR MONITOR STOCK CLOSELY STOCK IS AN EARLY ENTRY BUY CANDIDATE IF STOCK CLOSES ABOVE 33.30

I will make no bones about it. I like AVEI as an investment a whole lot right now, even though the stock is overbought. Those of you talking correctly about AVEI making possible acquisitions to broaden their product line are on the right track. Personally I am hoping they acquire ABMI because if they do I will have a nice hunk of AVEI myself.

Regards, Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext